At. Webb et al., LIPOPROTEIN (A) IN PATIENTS ON MAINTENANCE HEMODIALYSIS AND CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS, Nephrology, dialysis, transplantation, 8(7), 1993, pp. 609-613
Lipoprotein (a) concentrations and apoprotein (a) isoforms were measur
ed in 99 haemodialysis and 79 peritoneal dialysis patients and compare
d with a normal population. Peritoneal dialysis patients demonstrated
a threefold and haemodialysis a twofold increase in median Lp(a) value
s compared to controls (P less-than-or-equal-to 0.001). The peritoneal
dialysis group had significantly more patients with Lp(a) values grea
ter than 30 mg/dl compared to controls, (53% versus 22% P less-than-or
-equal-to 0.001). In addition both patient groups demonstrated signifi
cant' hypertriglyceridaemia (P less-than-or-equal-to 0.001), reduction
in HDL (P less-than-or-equal-to 0.001) and elevation of the cholester
ol/HDL ratio (P less-than-or-equal-to 0.001) compared with controls. P
eritoneal dialysis patients also demonstrated significant hypercholest
erolaemia (P less-than-or-equal-to 0.003). Lipoprotein (a) concentrati
ons are considerably elevated in patients on maintenance dialysis and
this occurs in addition to the typical lipoprotein disturbances. This
elevation may increase vascular risk, particularly in the peritoneal d
ialysis group who also have hypercholesterolaemia and reduced HDL.